Financials
Value Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 591.23 K573.54 K1.89 M1.5 M1.26 M1.14 M 5.79 M Research & development —6 30722.49 K5 97119.69 K14.54 K 62.69 K Operating income 1.42 M-295.91 K-1.7 M-604.89 K-991.84 K-894.81 K -4.19 M Non-Operating Income, Total -2 426-1 300-2.13 M3.79 M-5.11 M-3.29 M -6.74 M Interest expense, net of interest capitalized —1 30043.43 K194.08 K—— — Non-Operating Income, excl. Interest Expenses 0-1 300-43.43 K-194.08 K00 -237.52 K Unusual income/expense -2 426-1 300-2.13 M3.79 M-5.11 M-3.29 M -6.74 M Pretax income 1.41 M-297.21 K-3.83 M3.18 M-6.1 M-4.19 M -10.94 M Equity in earnings —————— — Taxes 0038.36 K663.6 K-701.96 K0 0 Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 349.2 K-297.21 K-3.87 M2.52 M-5.4 M-4.19 M -10.94 M Discontinued operations —————— — Net income 349.2 K-297.21 K-3.87 M2.52 M-5.4 M-4.19 M -10.94 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 349.2 K-297.21 K-3.87 M2.52 M-5.4 M-287.68 K -7.04 M Basic earnings per share (Basic EPS) —————— — Diluted earnings per share (Diluted EPS) 174.6 K1.64 M62.09 M18.37 M-75.05 M4.19 M 9.59 M Average basic shares outstanding —161.34 K276.26 K——— — Diluted shares outstanding 220 K20 K453.08 K1.25 M1.5 M — EBITDA —-279.69 K-1.68 M-588.67 K-976.6 K-880.07 K -4.13 M EBIT —-295.91 K-1.7 M-604.89 K-991.84 K-894.81 K -4.19 M Cost of revenue 0410.65 K402.93 K388.61 K246.47 K258.3 K 1.3 M Other cost of goods sold —————— — Depreciation & amortization (cash flow) —16.22 K16.22 K16.22 K15.24 K14.75 K 62.43 K